2026-05-26

Silver volume spike - 23.9× the 20-day average (43,933 vs 1,841 avg)

Platinum volume spike - 304.4× the 20-day average (15,416 vs 50 avg)

RBOB Gasoline bear 9.1% vs prior close ($3.45 → $3.14)

Copper volume spike - 23.6× the 20-day average (54,691 vs 2,316 avg)

Coffee volume spike - 3.6× the 20-day average (11,869 vs 3,304 avg)

Cocoa bull 9.4% vs prior close ($3,796.00 → $4,152.00)

Gold volume spike - 607.8× the 20-day average (250,910 vs 412 avg)

Heating Oil bear 7.2% vs prior close ($3.89 → $3.61)

10Y Treasury Note volume spike - 2.5× the 20-day average (6,134,453 vs 2,443,466 avg)

Cocoa volume spike - 3.1× the 20-day average (21,241 vs 6,856 avg)

OSINT: US KC-46A Tankers Deploy in Operation EPIC FURY Supporting #FreeIran

CFTC GOLD speculator at extreme short - contrarian bull signal

NATURAL GAS - speculators net long (+2.9σ vs 52w mean) - contrarian bear signal

OSINT: Iran's Internet Service Partially Restored After 3‑Month Blackout

Saudi Arabia (Dhahran): drought conditions detected - potential oil supply impact

OSINT: North Korea launches short-range ballistic missile 80km out to sea

OSINT: US CENTCOM Launches New Strikes in Iran After Recent IRGC Incident

30Y Treasury Bond volume spike - 2.3× the 20-day average (1,288,388 vs 561,750 avg)

COPPER - speculators net long (+2.4σ vs 52w mean) - contrarian bear signal

GOLD RSI 26.7 - oversold (crossed below 30)

HY spreads at distress levels - 700bps, recession-associated

HY spreads at distress levels - 700bps, recession-associated

HY spreads at distress levels - 700bps, recession-associated

HY spreads at distress levels - 700bps, recession-associated

HY spreads at distress levels - 700bps, recession-associated

Fed net liquidity surged $207bn in 4 weeks - significant injection, risk-on tailwind

china_us_west shipping +9.8% - potential inflation signal

china_us_west shipping +9.8% - potential inflation signal

china_us_west shipping +9.8% - potential inflation signal

FDA approves CLEOCIN (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves CLEOCIN (PFIZER) - new revenue stream

FDA approves DEPO-SUBQ PROVERA (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves DEPO-SUBQ PROVERA (PFIZER) - new revenue stream

FDA approves DEPO-SUBQ PROVERA (PFIZER) - new revenue stream

FDA approves CLEOCIN (PFIZER) - new revenue stream

Activist 13D filing - shareholder value

SPY RSI 71.8 - overbought (crossed above 70)

Q2-2025: Missed consensus by 98.0% - EPS $-2.24 vs $-1.1312 estimate

Q1-2026: Beat consensus by 13.0% - EPS $-0.58 vs $-0.6666 estimate

Q4-2025: Beat consensus by 147.7% - EPS $0.81 vs $-1.6968 estimate

Q3-2025: Beat consensus by 80.2% - EPS $-0.084 vs $-0.4242 estimate

Beat consensus by 22.8% - EPS $3.1 vs $2.525 estimate

Missed consensus by 31.0% - EPS $4.6 vs $6.666 estimate

Beat consensus by 132.7% - EPS $9.4 vs $4.04 estimate

Beat consensus by 14.0% - EPS $3.8 vs $3.333 estimate

Q1-2026: Beat consensus by 357.5% - EPS $0.35 vs $0.0765 estimate

Q4-2025: Missed consensus by 79.4% - EPS $0.3 vs $1.4581 estimate

Q3-2025: Missed consensus by 242.6% - EPS $-0.4 vs $0.2805 estimate

Q2-2025: Beat consensus by 81.8% - EPS $0.56 vs $0.3081 estimate

Q1-2026: Beat consensus by 15.5% - EPS $0.21 vs $0.1818 estimate

Beat consensus by 37.0% - EPS $-192000 vs $-304616 estimate

Q1-2026: Beat consensus by 15.1% - EPS $-0.2 vs $-0.2357 estimate

Q2-2025: Missed consensus by 26.0% - EPS $-0.176 vs $-0.1397 estimate

Q3-2025: Missed consensus by 94.8% - EPS $-0.31 vs $-0.1591 estimate

Q3-2025: Beat consensus by 26.1% - EPS $-0.69 vs $-0.9343 estimate

Q2-2025: Beat consensus by 21.6% - EPS $-3.47 vs $-4.4248 estimate

Beat consensus by 21.6% - EPS $-0.16 vs $-0.204 estimate

Q4-2025: Beat consensus by 37.9% - EPS $-0.22 vs $-0.3545 estimate

Q4-2025: Missed consensus by 7.8% - EPS $-1.31 vs $-1.2153 estimate

Q2-2025: Missed consensus by 5.8% - EPS $-1.07 vs $-1.0111 estimate

Q3-2025: Beat consensus by 53.1% - EPS $-0.34 vs $-0.7242 estimate

Q1-2026: Beat consensus by 14.2% - EPS $-0.42 vs $-0.4896 estimate

Beat consensus by 27.5% - EPS $-0.37 vs $-0.51 estimate

Q4-2025: Beat consensus by 36.0% - EPS $-0.32 vs $-0.4998 estimate

Q3-2025: Missed consensus by 7.0% - EPS $1.24 vs $1.3329 estimate

Beat consensus by 14.7% - EPS $0.75 vs $0.654 estimate

Missed consensus by 35.6% - EPS $-8.3 vs $-6.12 estimate

Missed consensus by 178.6% - EPS $-40.5 vs $-14.535 estimate

Missed consensus by 5.0% - EPS $-22.5 vs $-21.42 estimate

Q1-2026: Missed consensus by 1154.1% - EPS $-2.28 vs $-0.1818 estimate

Q1-2020: Missed consensus by 100.0% - EPS $0 vs $0.0612 estimate

Beat consensus by 9635.9% - EPS $14.59 vs $-0.153 estimate

Missed consensus by 233.3% - EPS $-0.68 vs $-0.204 estimate

Q1-2025: Beat consensus by 19.7% - EPS $-0.59 vs $-0.7344 estimate

Q3-2024: Missed consensus by 96.1% - EPS $-0.28 vs $-0.1428 estimate

Q2-2025: Beat consensus by 31.1% - EPS $-0.45 vs $-0.6528 estimate

Missed consensus by 7.1% - EPS $-1.53 vs $-1.428 estimate

Q4-2025: Beat consensus by 27.7% - EPS $-1.8 vs $-2.4888 estimate

Q2-2026: Missed consensus by 43.3% - EPS $-1.25 vs $-0.8721 estimate

Q3-2025: Missed consensus by 11.3% - EPS $-0.06 vs $-0.0539 estimate

Q1-2026: Beat consensus by 108.3% - EPS $0.01 vs $-0.1212 estimate

Q4-2025: Missed consensus by 22.2% - EPS $1.17 vs $1.5039 estimate

Q2-2025: Missed consensus by 11.4% - EPS $1.09 vs $1.2298 estimate

Q3-2025: Missed consensus by 27.9% - EPS $0.86 vs $1.1923 estimate

Q4-2025: Missed consensus by 298.1% - EPS $-0.67 vs $-0.1683 estimate

Q2-2025: Beat consensus by 44.0% - EPS $-0.06 vs $-0.1071 estimate

Q3-2025: Missed consensus by 66.9% - EPS $-0.12 vs $-0.0719 estimate

Q4-2025: Beat consensus by 32.8% - EPS $-0.09 vs $-0.1339 estimate

Q3-2025: Beat consensus by 186.6% - EPS $0.06 vs $-0.0693 estimate

Q2-2025: Beat consensus by 8.2% - EPS $0.12 vs $0.1109 estimate

Q3-2025: Beat consensus by 5.1% - EPS $0.35 vs $0.3329 estimate

Q1-2026: Beat consensus by 10.1% - EPS $0.25 vs $0.2271 estimate

Beat consensus by 47.7% - EPS $0.35 vs $0.237 estimate

Beat consensus by 16.2% - EPS $-5.5 vs $-6.565 estimate

Beat consensus by 8.6% - EPS $-6 vs $-6.565 estimate

Q1-2026: Beat consensus by 30.0% - EPS $2.17 vs $1.6687 estimate

Q4-2025: Beat consensus by 10.9% - EPS $2.09 vs $1.8847 estimate

Q2-2026: Beat consensus by 7.8% - EPS $2.27 vs $2.1054 estimate

Q3-2025: Beat consensus by 6.4% - EPS $1.76 vs $1.6538 estimate

Q3-2025: Missed consensus by 853.4% - EPS $-0.44 vs $0.0584 estimate

Q1-2026: Missed consensus by 106.3% - EPS $-5.2 vs $-2.5201 estimate

Q4-2025: Beat consensus by 64.6% - EPS $-0.44 vs $-1.2412 estimate

Missed consensus by 52.1% - EPS $-0.47 vs $-0.309 estimate

Q1-2026: Beat consensus by 60.7% - EPS $-0.13 vs $-0.3311 estimate

Q3-2025: Missed consensus by 6.2% - EPS $-0.32 vs $-0.3013 estimate

Q2-2025: Missed consensus by 5.6% - EPS $-0.31 vs $-0.2935 estimate

Q4-2025: Missed consensus by 10.0% - EPS $-0.3 vs $-0.2728 estimate

Q1-2026: Missed consensus by 404.1% - EPS $-0.92 vs $-0.1825 estimate

Q4-2025: Missed consensus by 108.3% - EPS $-0.29 vs $-0.1392 estimate

Q3-2025: Missed consensus by 39.1% - EPS $-0.08 vs $-0.0575 estimate

Q2-2025: Beat consensus by 23.8% - EPS $-0.05 vs $-0.0656 estimate

Q1-2026: Missed consensus by 38.3% - EPS $0.25 vs $0.4049 estimate

Q2-2025: Missed consensus by 7.8% - EPS $0.42 vs $0.4553 estimate

Q3-2025: Beat consensus by 6.0% - EPS $0.47 vs $0.4434 estimate

Q2-2025: Beat consensus by 9.0% - EPS $2.86 vs $2.6232 estimate

Q2-2025: Missed consensus by 16.3% - EPS $0.1 vs $0.1195 estimate

Q3-2025: Beat consensus by 9.4% - EPS $2.5 vs $2.2855 estimate

Q4-2025: Beat consensus by 10.8% - EPS $2.62 vs $2.3636 estimate

Q2-2025: Beat consensus by 15.5% - EPS $3.09 vs $2.6752 estimate

Q1-2026: Beat consensus by 11.9% - EPS $3.04 vs $2.7166 estimate

Q4-2025: Beat consensus by 10.8% - EPS $0.47 vs $0.4241 estimate

Q1-2026: Missed consensus by 11.2% - EPS $0.79 vs $0.8901 estimate

Q3-2025: Beat consensus by 13.7% - EPS $0.33 vs $0.2902 estimate

Q2-2025: Beat consensus by 21.9% - EPS $0.38 vs $0.3118 estimate

Missed consensus by 17.1% - EPS $47.75 vs $57.57 estimate

Missed consensus by 52.4% - EPS $-50.78 vs $-33.33 estimate

Missed consensus by 30.3% - EPS $69.68 vs $99.99 estimate

Beat consensus by 193.3% - EPS $13.19 vs $-14.14 estimate

Q2-2025: Beat consensus by 5.7% - EPS $2.7 vs $2.5553 estimate

Q2-2025: Beat consensus by 37.0% - EPS $-0.14 vs $-0.2222 estimate

Q4-2025: Missed consensus by 122.8% - EPS $-0.18 vs $-0.0808 estimate

Missed consensus by 375.2% - EPS $-0.48 vs $-0.101 estimate

Q4-2025: Beat consensus by 5.9% - EPS $3.15 vs $2.9742 estimate

Q2-2025: Beat consensus by 5.2% - EPS $2.78 vs $2.6428 estimate

Beat consensus by 6.1% - EPS $3.22 vs $3.034 estimate

Missed consensus by 7.8% - EPS $-16.5 vs $-15.3 estimate

Beat consensus by 26.5% - EPS $-4.5 vs $-6.12 estimate

Beat consensus by 21.6% - EPS $-6 vs $-7.65 estimate

Missed consensus by 17.6% - EPS $-9 vs $-7.65 estimate

Q3-2025: Beat consensus by 16.0% - EPS $0.55 vs $0.4743 estimate

Q4-2025: Missed consensus by 25.8% - EPS $0.43 vs $0.5794 estimate

Q4-2025: Beat consensus by 19.8% - EPS $0.29 vs $0.2421 estimate

Q3-2025: Beat consensus by 6.3% - EPS $0.23 vs $0.2163 estimate

Q2-2025: Beat consensus by 17.3% - EPS $0.82 vs $0.6989 estimate

Missed consensus by 18.3% - EPS $0.57 vs $0.698 estimate

Q1-2026: Beat consensus by 14.4% - EPS $0.82 vs $0.7166 estimate

Q2-2026: Beat consensus by 15.6% - EPS $0.22 vs $0.1903 estimate

Q3-2026: Beat consensus by 14.5% - EPS $0.27 vs $0.2359 estimate

Q4-2025: Beat consensus by 10.7% - EPS $0.13 vs $0.1174 estimate

Q1-2026: Beat consensus by 11.3% - EPS $0.15 vs $0.1348 estimate

Q1-2026: Beat consensus by 13.2% - EPS $-0.05 vs $-0.0576 estimate

Beat consensus by 14.3% - EPS $-0.06 vs $-0.07 estimate

Q3-2025: Beat consensus by 20.0% - EPS $-0.39 vs $-0.4874 estimate

Q3-2025: Missed consensus by 139.3% - EPS $-0.33 vs $0.8403 estimate

Q4-2025: Missed consensus by 312.9% - EPS $-1.86 vs $0.8737 estimate

Q2-2025: Missed consensus by 96.1% - EPS $0.03 vs $0.7696 estimate

Q1-2026: Missed consensus by 91.0% - EPS $0.07 vs $0.7807 estimate

Missed consensus by 98.0% - EPS $-3.6 vs $-1.818 estimate

Missed consensus by 174.3% - EPS $-3 vs $4.04 estimate

Missed consensus by 18.8% - EPS $-2.4 vs $-2.02 estimate

Q1-2026: Missed consensus by 10.9% - EPS $1.1 vs $1.2342 estimate

Missed consensus by 33.9% - EPS $0.16 vs $0.242 estimate

Q4-2025: Beat consensus by 11.2% - EPS $0.41 vs $0.3686 estimate

Q2-2025: Missed consensus by 27.7% - EPS $0.14 vs $0.1937 estimate

Q1-2026: Beat consensus by 37.9% - EPS $0.191 vs $0.1385 estimate

Q4-2025: Missed consensus by 65.0% - EPS $-0.6 vs $-0.3636 estimate

Q1-2025: Missed consensus by 8.0% - EPS $-0.3 vs $-0.2778 estimate

Q2-2025: Missed consensus by 30.7% - EPS $-0.35 vs $-0.2677 estimate

Q3-2025: Missed consensus by 41.2% - EPS $-0.41 vs $-0.2904 estimate

Q1-2026: Beat consensus by 29.5% - EPS $-0.24 vs $-0.3405 estimate

Beat consensus by 19.8% - EPS $0.52 vs $0.434 estimate

Q3-2026: Beat consensus by 23.0% - EPS $0.56 vs $0.4552 estimate

Q2-2025: Missed consensus by 1768.8% - EPS $-1.51 vs $-0.0808 estimate

Q1-2026: Missed consensus by 424.3% - EPS $-0.95 vs $0.2929 estimate

Q3-2025: Missed consensus by 60.4% - EPS $0.02 vs $0.0505 estimate

Q4-2025: Missed consensus by 1765.7% - EPS $-2.86 vs $0.1717 estimate

Q1-2026: Beat consensus by 45.8% - EPS $-0.26 vs $-0.4794 estimate

Q4-2025: Beat consensus by 123.1% - EPS $0.1 vs $-0.4335 estimate

Q2-2026: Beat consensus by 58.7% - EPS $-0.12 vs $-0.2907 estimate

Beat consensus by 8.1% - EPS $-0.5 vs $-0.544 estimate

Q3-2025: Beat consensus by 39.6% - EPS $-0.09 vs $-0.1489 estimate

Missed consensus by 194.1% - EPS $-0.15 vs $-0.051 estimate

Q1-2026: Missed consensus by 11.8% - EPS $-0.13 vs $-0.1163 estimate

Q2-2025: Missed consensus by 43.2% - EPS $-1.2 vs $-0.8381 estimate

Q4-2025: Missed consensus by 6.3% - EPS $-1.39 vs $-1.3073 estimate

Q1-2026: Missed consensus by 24.9% - EPS $-1.69 vs $-1.3535 estimate

Q3-2025: Missed consensus by 8.8% - EPS $-1.26 vs $-1.1585 estimate

Missed consensus by 139.2% - EPS $-0.44 vs $1.122 estimate

Missed consensus by 21.6% - EPS $0.76 vs $0.969 estimate

Q3-2025: Beat consensus by 78.7% - EPS $-0.48 vs $-2.2542 estimate

Q4-2025: Missed consensus by 22.5% - EPS $-0.35 vs $-0.2856 estimate

Q1-2026: Missed consensus by 18.5% - EPS $-0.29 vs $-0.2448 estimate

Q4-2025: Missed consensus by 5.0% - EPS $-0.3 vs $-0.2856 estimate

Beat consensus by 41.2% - EPS $-0.15 vs $-0.255 estimate

Q4-2025: Missed consensus by 78.7% - EPS $-1.03 vs $-0.5763 estimate

Q1-2026: Beat consensus by 42.8% - EPS $-0.28 vs $-0.4896 estimate

ETH DEX volume/liquidity ratio elevated (0.51x) - strong on-chain trading activity